SCHEMBL26536414

SCHEMBL26536414

c1ccc(-c2cc(-c3ccccc3)cc(-c3ccc4c(c3)[nH]c3ccc5c6ccccc6sc5c34)c2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK4 P11802 3/20 0.49
▸ CCND1 P24385 3/20 0.49
▸ TNKS2 Q9H2K2 3/20 0.43
▸ TNKS O95271 2/20 0.43
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ HCRTR1 O43613 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ GABRP O00591 1/20 0.38
▸ GABRD O14764 1/20 0.38
▸ GABRA1 P14867 1/20 0.38
▸ GABRB1 P18505 1/20 0.38
▸ GABRG2 P18507 1/20 0.38
▸ GABRB3 P28472 1/20 0.38
▸ GABRA5 P31644 1/20 0.38
▸ GABRA3 P34903 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17117711 0.97 CDK4 (0.49) CDK4CCND1TNKS2TNKSMEN1
SCHEMBL14653419 0.97 CDK4 (0.51) CDK4CCND1TNKS2TNKSMEN1
SCHEMBL17117700 0.97 CDK4 (0.51) CDK4CCND1TNKS2TNKSMEN1
SCHEMBL14652763 0.89 CDK4 (0.49) CDK4CCND1TNKS2TNKSMEN1
SCHEMBL30104215 0.89 CDK4 (0.49) CDK4CCND1TNKS2TNKSMEN1
SCHEMBL17117708 0.88 TNKS2 (0.43) CDK4CCND1TNKS2TNKSMEN1
SCHEMBL25681661 0.86 GABRP (0.46) CDK4CCND1TNKS2TNKSMEN1
SCHEMBL14951590 0.85 GABRA1 (0.45) CDK4CCND1TNKS2TNKSMEN1
SCHEMBL17117702 0.84 ALOX5 (0.56) CDK4CCND1TNKS2TNKSMEN1
SCHEMBL26536418 0.84 TNKS2 (0.41) CDK4CCND1TNKS2TNKSMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230322802-A1 LIGHT EMITTING DEVICE AND FUSED POLYCYCLIC COMPOUND FOR THE LIGHT EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-10-12 — — US disclosed
US-20230322802-A1 LIGHT EMITTING DEVICE AND FUSED POLYCYCLIC COMPOUND FOR THE LIGHT EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-10-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230322802-A1 LIGHT EMITTING DEVICE AND FUSED POLYCYCLIC COMPOUND FOR THE LIGHT EMITTING DEVICE CRY1, LAGE3, CRY2 CDK4 1307/4885CCND1 1586/4885TNKS2 1405/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback